JEREMY WADDELL: Open Payments
NPI 1649469552 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 45 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $970 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $150 |
| Novo Nordisk Inc | 7 | $142 |
| ABBVIE INC. | 6 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| Axsome Therapeutics, Inc. | 3 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
| Lundbeck LLC | 3 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Abbott Laboratories | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $44 |
Products named: REXULTI, VRAYLAR, Auvelity, FARXIGA, FANAPT, Ozempic, CAPLYTA, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
